At a glance
- Originator Unknown
- Developer Wyeth
- Class Antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis
Most Recent Events
- 31 Aug 1998 No-Development-Reported for Allergic rhinitis in USA (PO)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Allergic rhinitis in USA (PO)